May 12 (Reuters) - Alpine Immune Sciences Inc ALPN.O :
* ALPINE IMMUNE SCIENCES PROVIDES CORPORATE UPDATE AND
REPORTS
FIRST QUARTER 2022 FINANCIAL RESULTS
* ALPINE IMMUNE SCIENCES INC- AS OF MARCH 31, 2022, WE HAD
CASH,
CASH EQUIVALENTS, AND INVESTMENTS TOTALING $219.1 MILLION
* ALPINE IMMUNE SCIENCES INC- EXPECTS THAT ITS CURRENT CASH
RESOURCES WILL BE SUFFICIENT TO FUND ITS PLANNED OPERATIONS INTO
2024
* ALPINE IMMUNE SCIENCES INC - QTRLY LOSS PER SHARE $0.25
* ALPINE IMMUNE SCIENCES INC- COLLABORATION REVENUE FOR Q1
ENDED
MARCH 31, 2022 WAS $13.6 MILLION COMPARED TO $3.2 MILLION FOR Q1
ENDED MARCH 31, 2021
Source text for Eikon: ID:nBw9xg5Ksa
Further company coverage: ALPN.O
((Reuters.Briefs@thomsonreuters.com;))